App-Quantinova.ai

BENEFIT AND RISK OF DUAL ANTIPLATELET THERAPY IN FEMALES: DAPT STUDY RESULTS

Natalia Berry - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Aspirin

BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF >40,000 PATIENTS

Ashish Adrian Correa - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Bivalirudin

MORPHINE USE IMPAIRS THROMBOTIC STATUS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Mohamed Farag - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

TIMING OF PCI IN PATIENTS WITH NON-ST-ELEVATION MYOCARDIAL INFARCTION: A SWEDEHEART STUDY

Christoph Varenhorst - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

SAFETY AND EFFICACY OF THE COMBINATION SIROLIMUS-ELUTING ENDOTHELIAL PROGENITOR CELL CAPTURE STENT IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ONE YEAR FOLLOW-UP

Joshua Ping Yun Loh - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rapacan

IDENTIFICATION OF NOVEL CYP2C19 GENETIC VARIANTS IN PATIENTS WITH DEFINITE STENT THROMBOSIS: AN IN-DEPTH SEQUENCING STUDY

Kashish Goel - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

PROPENSITY-SCORE COMPARISON OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION BY RADIAL VERSUS FEMORAL APPROACH

Daniel Diehl - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

LONG-TERM (7-YEAR) CLINICAL OUTCOMES OF BIFURCATION LESIONS AFTER BIODEGRADABLE POLYMER-BASED BIOMATRIX BIOLIMUS-ELUTING STENT IMPLANTATION ACCORDING TO STENTING STRATEGY

Masanobu Ohya - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Umirolimus

TICAGRELOR VERSUS TICAGRELOR AND CLOPIDOGREL IN PATIENTS UNDERGOING PRIMARY PCI: A PLATELET REACTIVITY PHARMACODYNAMICS STUDY

Benjamin M. Hibbert - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

THROMBUS LYMPHOCYTE PHENOTYPING IN ACUTE MYOCARDIAL INFARCTION

Anna Toso - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

N/A

COMPARISON OF HISTOPATHOLOGICAL ANALYSIS OF INTRACORONARY THROMBUS ASPIRATED BY THROMBECTOMY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST-SEGMENT ELEVATION

Roberta Montisci - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

CONFLICTING RESULTS BETWEEN RANDOMIZED TRIALS AND OBSERVATIONAL STUDIES ON THE IMPACT OF PROTON PUMP INHIBITORS ON CARDIOVASCULAR EVENTS

Chiara Melloni - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Omeprazole

INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION

Yoon Seok Koh - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

IMPACT OF SMOKING STATUS ON CLINICAL OUTCOMES WITH PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES MANAGED WITHOUT revascularization: INSIGHTS FROM THE TRILOGY ACS TRIAL

J.H. Cornel - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

PROGNOSTIC VALUE OF NEUTROPHIL/LYMPHOCYTE RATIO IN PATIENTS WITH STEMI UNDERGOING PRIMARY CORONARY INTERVENTION: TEN-YEAR FOLLOW-UP RESULTS OF MULTICENTER EXPERIENCES

Mehmet Kaya - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE PROGNOSTIC IMPACT OF RENAL DYSFUNCTION AND ANEMIA IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Koki Shishido - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

PAR-1 ANTAGONIST VORAPAXAR IMPROVES GLOBAL THROMBOTIC STATUS IN PATIENTS WITH CORONARY DISEASE

Diana A. Gorog - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Vorapaxar

ABSENCE OF QTC PROLONGATION WITH BETRIXABAN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND POSITIVE-CONTROLLED THOROUGH ECG STUDY

Uma Sinha - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Moxifloxacin

POST-PROCEDURAL DABIGATRAN VERSUS STANDARD ANTICOAGULATION IN ABLATION FOR ATRIAL FIBRILLATION

Jeffrey Lin - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Pradax

INCIDENCE, CHARACTERISTIC AND RISK FACTORS OF CEREBRAL THROMBOEMBOLIC COMPLICATIONS FOLLOWING HIGH-FREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION: EXPERIENCE OF 3,360 PROCEDURES

Andreas Bollmann - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Heparin

Filters

7277 Abstracts